Dr William Chi-shing Cho is a scientific officer at the Department of Clinical Oncology in Queen Elizabeth Hospital. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He holds an international patent for serum biomarkers in lung cancer under the USA Patent Cooperation Treaty. He is a Chartered Scientist granted by the Science Council (UK) and a fellow member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences.
Dr Cho has published over 200 papers and plenty of books covering cancer biomarkers, proteomics and microRNAs. He serves as the editor-in-chief, editor and associate editor of a number of international medical journals. Dr Cho is also is a reviewer of many prestigious international journals and as an international grant reviewer of the Hope Funds for Cancer Research (USA), Cancer Research UK, Science Foundation (Ireland), National Medical Research Council (Singapore), and Academia Sinica Investigator Award (Taiwan).
The Role of the Editor in Chief
The editor in chief is responsible for editorial decision-making on papers submitted to the journal. The editor in chief is also responsible for editorial matters that include but are not limited to journal supplements, the journal's aims and scope, the editorial board and volunteer peer reviewer pool, editorial assessment of video abstracts, assignment to published papers of endorsements, and for consulting on pre-submission inquiries from authors.